Bictegravir-emtricitabine-tenofovir is prescribed for:
- HIV-1 infection treatment
- Complete single-tablet regimen
- Treatment-naive and treatment-experienced patients
- Immunology infectious disease
One of the most commonly prescribed HIV regimens.
Back to Medication Guide
Bictegravir-Emtricitabine-Tenofovir
Generic Name: Bictegravir/Emtricitabine/Tenofovir Alafenamide
Brand Names: Biktarvy
Biktarvy is a complete single-tablet HIV treatment regimen combining an integrase inhibitor with two NRTIs.
AntiviralHIV
What It's Used For
Side Effects
Common side effects:
- Diarrhea
- Nausea
- Headache
- Fatigue
Serious side effects:
- Lactic acidosis
- Severe hepatitis B flare upon discontinuation
- Immune reconstitution syndrome
Additional Information
What is Biktarvy?
Biktarvy combines bictegravir (integrase inhibitor) with emtricitabine and tenofovir alafenamide (TAF) - a safer tenofovir formulation.
High Efficacy
High barrier to resistance with excellent tolerability, making it a first-line option for many patients.
TAF vs TDF
Uses TAF instead of TDF, which has less impact on kidneys and bone density.
Learn more at MedlinePlus.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Bictegravir-Emtricitabine-Tenofovir? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.